327 related articles for article (PubMed ID: 28273385)
1. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
[TBL] [Abstract][Full Text] [Related]
2. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?
Vos R; Vanaudenaerde BM; Geudens N; Dupont LJ; Van Raemdonck DE; Verleden GM
Eur Respir J; 2008 May; 31(5):1037-45. PubMed ID: 18256072
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
5. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
7. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
9. De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
Morrell MR; Pilewski JM; Gries CJ; Pipeling MR; Crespo MM; Ensor CR; Yousem SA; D'Cunha J; Shigemura N; Bermudez CA; McDyer JF; Zeevi A
J Heart Lung Transplant; 2014 Dec; 33(12):1288-94. PubMed ID: 25443870
[TBL] [Abstract][Full Text] [Related]
10. Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients.
Vital D; Hofer M; Benden C; Holzmann D; Boehler A
Respiration; 2013; 86(1):25-31. PubMed ID: 22922656
[TBL] [Abstract][Full Text] [Related]
11. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
Hadjiliadis D; Davis RD; Palmer SM
Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
[TBL] [Abstract][Full Text] [Related]
12. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
[TBL] [Abstract][Full Text] [Related]
14. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
15. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome.
Willner DL; Hugenholtz P; Yerkovich ST; Tan ME; Daly JN; Lachner N; Hopkins PM; Chambers DC
Am J Respir Crit Care Med; 2013 Mar; 187(6):640-7. PubMed ID: 23328523
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome.
Botha P; Archer L; Anderson RL; Lordan J; Dark JH; Corris PA; Gould K; Fisher AJ
Transplantation; 2008 Mar; 85(5):771-4. PubMed ID: 18337673
[TBL] [Abstract][Full Text] [Related]
17. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study.
Law N; Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Ussetti P; Chin-Hong PV; Sole A; Holmes-Liew CL; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Younus M; Aram J; Chaparro C; Singer LG; Husain S
J Heart Lung Transplant; 2019 Sep; 38(9):963-971. PubMed ID: 31300191
[TBL] [Abstract][Full Text] [Related]
19. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
Jain R; Hachem RR; Morrell MR; Trulock EP; Chakinala MM; Yusen RD; Huang HJ; Mohanakumar T; Patterson GA; Walter MJ
J Heart Lung Transplant; 2010 May; 29(5):531-7. PubMed ID: 20133163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
